Related Experiment Videos

[Gene therapy for hepatocellular carcinoma]

M Ohashi¹, F Kanai, Y Shiratori

¹Division of Gastroenterology, Department of Internal Medicine, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|January 5, 2002

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Adenovirus-mediated drug-sensitivity gene therapy for hepatocellular carcinoma.

Methods in molecular medicine·2011

Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.

Journal of viral hepatitis·2010

Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors.

Journal of viral hepatitis·2009

Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH.

Gut·2009

Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.

Oncogene·2005

The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.

Oncogene·2005

See all related articles